Our client, a leading developer and manufacturer of human cells used in drug discovery, toxicity testing, stem cell banking, and cell therapy development, wanted to understand more about the market for these technologies in China, in particular from the contract research outsourcing market. The scope of the study is as follows:
• Market Overview And Size
• Contract Research Outsourcing Trends
• Key Players And Competitors
• Adoption And Application Of Technologies
• Market Opportunities And Challenges
• Regulatory And Operational Considerations
Market Segmentation and Overview
• Drug discovery services and technologies market with segmentation
• Cell-based drug discovery and stem cells market with segmentation
Market Size and Forecast
• Historic and forecasted market size for both global and China markets
Technologies and Trends
• Key technologies and emerging trends in the sector
Competitive Landscape
• Overview of competitors
End Users
• Analysis of end-user segments
Primary Research:
• Conducted expert interviews to refine market estimates and validate segmentation approaches
• Triangulated figures for drug discovery and stem cells markets as a sanity check on numbers
Secondary Research:
• Conducted detailed and fully referenced research using public and proprietary datasets
• Worked down from reliable estimates of parent markets through a series of segmentations based on secondary research
• Enabled the client to gain insights into the IPS cell market for drug discovery in China
• Supported the client in identifying opportunities to capitalize on and threats to mitigate
• Delivered actionable findings to guide strategic decisions in the market